299 related articles for article (PubMed ID: 25099702)
1. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity.
Hoerning A; Wilde B; Wang J; Tebbe B; Jing L; Wang X; Jian F; Zhu J; Dolff S; Kribben A; Hoyer PF; Witzke O
Transplantation; 2015 Jan; 99(1):210-9. PubMed ID: 25099702
[TBL] [Abstract][Full Text] [Related]
2. P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus.
Wang JY; Fan H
Chin Med J (Engl); 2015 Mar; 128(5):664-9. PubMed ID: 25698201
[TBL] [Abstract][Full Text] [Related]
3. Performance of a phosphoflow assay to determine phosphorylation of S6 ribosomal protein as a pharmacodynamic read out for mTOR inhibition.
Abdel-Kahaar E; Kabakchiev M; Hartmann B; Wieland E; Shipkova M
Clin Biochem; 2016 Oct; 49(15):1181-1187. PubMed ID: 27372285
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
Chu ZQ; Ji Q
Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
[TBL] [Abstract][Full Text] [Related]
5. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
Dieterlen MT; Bittner HB; Klein S; von Salisch S; Mittag A; Tárnok A; Dhein S; Mohr FW; Barten MJ
Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594
[TBL] [Abstract][Full Text] [Related]
6. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of P70S6 kinase phosphorylation after liver transplantation by phospho-flow cytometry].
Wang J; Fan H
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(48):3809-12. PubMed ID: 25623311
[TBL] [Abstract][Full Text] [Related]
8. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
9. Monitoring biological action of rapamycin in renal transplantation.
Leogrande D; Teutonico A; Ranieri E; Saldarelli M; Gesualdo L; Schena FP; Di Paolo S
Am J Kidney Dis; 2007 Aug; 50(2):314-25. PubMed ID: 17660033
[TBL] [Abstract][Full Text] [Related]
10. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study.
Zhao T; Yang C; Qiu Y; Xue Y; Zhao Z; Song D; Qiu Y; Ma Z; Yang B; Xu M; Rong R; Zhu T
Transplant Proc; 2013; 45(1):148-52. PubMed ID: 23375289
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
12. Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy.
Hartmann B; Schmid G; Graeb C; Bruns CJ; Fischereder M; Jauch KW; Heeschen C; Guba M
Kidney Int; 2005 Dec; 68(6):2593-8. PubMed ID: 16316335
[TBL] [Abstract][Full Text] [Related]
13. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
Mittal SK; Sharma RK; Gupta A; Naik S
Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
[TBL] [Abstract][Full Text] [Related]
14. Assessing the efficacy of mammalian target of rapamycin inhibitors by phosphorylation of p70S6K in CD4-positive cells of liver transplant patients.
Wang JY; Fan H
Medicine (Baltimore); 2019 Oct; 98(43):e17457. PubMed ID: 31651849
[TBL] [Abstract][Full Text] [Related]
15. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
17. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
[TBL] [Abstract][Full Text] [Related]
18. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic Monitoring of mTOR Inhibitors.
Millán O; Wieland E; Marquet P; Brunet M
Ther Drug Monit; 2019 Apr; 41(2):160-167. PubMed ID: 30883509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
